Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50%
MEI Pharma's Litecoin initiative signals growing institutional crypto adoption, potentially boosting Litecoin's legitimacy and market presence. The post Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, sto...
Archive context
Older archive item. Useful for background and entity history, but not a fresh market-moving signal.
MEI Pharma's Litecoin initiative signals growing institutional crypto adoption, potentially boosting Litecoin's legitimacy and market presence.
The post Nasdaq-listed MEI Pharma launches $100M Litecoin treasury plan, stock rockets 50% appeared first on Crypto Briefing.
Why this matters
This research story adds another data point to the current market tape and is useful when read alongside nearby source coverage.
Original source
Read on Crypto BriefingRelated market context
Ripple Prime launches 24/7 RWA swaps for institutional clients
Ripple Prime's 24/7 RWA swaps could enhance XRP's utility and adoption, potentially influencing its market position and price dyna...
XRP Price Prediction: Evernorth’s $648M Game Plan Takes Shape
XRP trades at $1.30, down 6% over 24 hours, as traders weigh sticky U.S. inflation against a major institutional treasury plan. Ev...
Avanza Bank holds $298K in shares of Bitcoin treasury company Strategy
Avanza Bank's indirect Bitcoin exposure highlights the growing trend of cautious institutional investment in cryptocurrency throug...
EQX Plans 11 Tokenized Stock and ETF Markets on Hyperliquid
The share-backed tokens would trade on HyperCore against USDC, with US persons excluded under EQX’s eligibility rules.... Read the...
Ripple Prime launches 24/7 perpetual swaps on traditional assets for institutions
Ripple Prime's 24/7 perpetual swaps could revolutionize institutional trading by enhancing liquidity access and risk management be...
Hyperliquid expands tokenized stock offerings with EQX launch
EQX plans to launch 11 tokenized US stocks and ETFs on Hyperliquid, offering 24/7 spot trading, share backing, dividend reinvestme...